M42’s IROS Launches UAE’s First Genomics-Driven Clinical Trial to Prevent Alzheimer’s Disease
Abu dhabi: M42’s Insights Research Organisation and Solutions (IROS), in collaboration with the Department of Health – Abu Dhabi (DoH) and Halia Therapeutics, a US-based clinical-stage biotechnology company, has launched the UAE’s first genomics-drive…